Product Information
LEVONOR-ETH ESTRAD TRIPHASIC is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3429 per EA under NDC 68180085773. Its NADAC has been published 286 times since Jan 6, 2021.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180085773
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA200248On Market Since
8/30/2020
Price Statistics
The NADAC for LEVONOR-ETH ESTRAD TRIPHASIC has been published 286 times since Jan 6, 2021, and over the history we have for it it has declined 26.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3429 per EA |
|---|---|
| All-time high | $0.5249 (Apr 14, 2021) |
| All-time low | $0.2138 (Jul 17, 2024) |
| 52-week high | $0.4387 |
| 52-week low | $0.2829 |
| Median price | $0.3548 |
| Average price | $0.3612 |
| Largest weekly change | +85.8% (Nov 22, 2023) |
| Weeks tracked | 286 |
| Tracking since | Jan 6, 2021 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 67% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVONOR-ETH ESTRAD TRIPHASIC?
The current National Average Drug Acquisition Cost (NADAC) for LEVONOR-ETH ESTRAD TRIPHASIC, manufactured by Lupin Pharmaceuticals Inc., is $0.3429 per EA (NDC 68180085773), effective Jun 24, 2026.
How has the price of LEVONOR-ETH ESTRAD TRIPHASIC changed over time?
Over the history we have for it, the NADAC for LEVONOR-ETH ESTRAD TRIPHASIC has declined 26.9%. It has been tracked across 286 weekly CMS publications since Jan 6, 2021.
What are the highest and lowest recorded NADAC prices for LEVONOR-ETH ESTRAD TRIPHASIC?
Since Jan 6, 2021, the NADAC for LEVONOR-ETH ESTRAD TRIPHASIC has ranged from a low of $0.2138 (Jul 17, 2024) to a high of $0.5249 (Apr 14, 2021), with a median of $0.3548 per EA.
Are there cheaper alternatives to LEVONOR-ETH ESTRAD TRIPHASIC?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1125 per EA — about 67% below LEVONOR-ETH ESTRAD TRIPHASIC.
Who manufactures LEVONOR-ETH ESTRAD TRIPHASIC?
LEVONOR-ETH ESTRAD TRIPHASIC (NDC 68180085773) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification